BRCA1 and BRCA2 Germline Mutations Screening in Algerian Breast/Ovarian Cancer Families
Background: Breast cancer is the leading cause of cancer death in women in Algeria. The contribution of BRCA1 and BRCA2 mutations to hereditary breast/ovarian cancer in Algerian population is largely unknown. Here, we describe analysis of BRCA1 and BRCA2 genes in 86 individuals from 70 families from...
Main Authors: | Farid Cherbal, Rabah Bakour, Saida Adane, Kada Boualga, Gaelle Benais-Pont, Philippe Maillet |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2010-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.3233/DMA-2010-0718 |
Similar Items
-
BRCA1 and BRCA2 Unclassified Variants and Missense Polymorphisms in Algerian Breast/Ovarian Cancer Families
by: Farid Cherbal, et al.
Published: (2012-01-01) -
Contribution of BRCA1 and BRCA2 Germline Mutations to Early Algerian Breast Cancer
by: Sarra Henouda, et al.
Published: (2016-01-01) -
BRCA germline mutation test for all woman with ovarian cancer?
by: A. V. Paradiso, et al.
Published: (2019-06-01) -
Frequency of germline mutations in BRCA1 and BRCA2 in ovarian cancer patients and their effect on treatment outcome
by: Ashour M, et al.
Published: (2019-07-01) -
An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers
by: Ewa Przybytkowski, et al.
Published: (2020-03-01)